Professional Documents
Culture Documents
Effects of Oral Hypoglycemic Drugs On Flow Rate and Protein Composition of Saliva in Pa-Tients With Diabetes Mellitus
Effects of Oral Hypoglycemic Drugs On Flow Rate and Protein Composition of Saliva in Pa-Tients With Diabetes Mellitus
net/publication/332720116
CITATIONS READS
0 50
1 author:
SEE PROFILE
Some of the authors of this publication are also working on these related projects:
All content following this page was uploaded by Faehaa Azher Al-Mashhadane on 28 April 2019.
الخالصة
معرفةةت ثةةكل نةةر مةةس مةةرأل ويةةةملر خومةخيفةةت و ةةةجر مت ت ورمةةو ىونةةة و اج ةةل مب وامل تةةةات مريفةةة وياعةةة خو ةةةجل ويملاة:الهد م ددد ال ا ددة
: ىة ر و راةةمل المدددا والطرائد ة ت وي ة ية وم ة ةر خح يفة ياربخثانةةةيف ت وياعةةة ونة و راةةمل و ءةةةسب سة ور ويةةةملر خمنةةة تجء سةم ةةرة
منء نةةتلو أ ةرة أ ة ةر خع ووجاةة ى ة لوةت أخو ىة لوةت سةامرع و لوةت84 ، إتةث81 ، ذنل72رص ى 54أمريفت ىذه وي وست وامل
مةريف مءةة سة ور ويةةملر84 مءةة سة ور ويةةملر خل يفجانةمل أ تةلل مةس ويعرمةةيف أمةة و لوةت ويثةيثةت فججملةل مةريف84ويثةتات خوييت ثجملل مس
مةمعت و ل ر ع مجع وانةت وياعةة خقاةةس تةةات/ ناات طب ومسنة/ ع وخجاة و رامل مس قة مروحت ويلمو خوي ملب خيفجعةجل سعنة و اج ل مب فنط
Green and Vermillionةرص ن ةة ع ح يفة ة ت وي ة يملةر مةنء حةةب م ةر ة ت وي ة و اةةط ى وجلريفة خمةجل ويربخثةب يملةر
، ع مرحظت خملة فرخق معنليفت سب ةةماع وي وست نةفتOne way analysis of variance ون إمرور ويج اار وإلحءةئ سمريفنت:النتائج
Duncan's multiple analysis range test ن ةة أهءةريف تجةةئإل وإلحءةةر حةةب،يملر مس تةات مريفة وياعة خمةجل ويربخثةب فاةو
سان ةة دة فرخقةةيف معنليفةت سةب و ةلوجب،أتو يفلم فرخقةيف معنليفةت يملةر مةس تةةات مريفةة وياعةة خمةةجل ويربخثةب فاةو سةب و ةلوجب ومخو خويثةيثةت
، ل يفملةس ىنةةأ أ فةرق معنةل سةب و ةلوجب ومخو خويثةيثةت، ومخو خويثةتات خنذيك سب و لوت ويثةتات خويثةيثت أمة سةينةات إو تجةئإل قاةس ة ت وي ة
إ مةرأل ويةةملر نملةس أ ة ث ث اة و ت:سان ة خم ىذو وي رق و عنل سب و لوجب ومخو خويثةتات خنذيك سب و لوت ويثةتات خويثةيثةت اإل تنتاج
خويةةذ سة خ ه نملةةس أ يفة لر واةةمل ة ت وي ة ون ة مراةةمل ويةةةملر سان ةةة حة ث ومةخيفةةت خويعنةةةق وي ليفةةت،معة ج مريفةةة وياعةةة خمةةةجل ويربخثةةب
و ةجع ات يعرج ويةملر مثر ىذو ويجكل
ABSTRACT
Aims: To study the effects of both diabetes mellitus and oral hypoglycemic drugs (metfomin) on sali-
vary flow rate and total protein levels of saliva and to compare them with control healthy subjects and
to determine their effects on oral health of these patients. Materials and Methods: This study was
carried out on 45 individuals (27 males and 18 females); 15 individuals of them were healthy subjects
and considered as control group. The second group which comprised 15 patients with diabetes mellitus
and received no any treatment (uncontrolled).The third group, diabetic patients were treated with met-
formin only. Subjects were selected from the out patients attending Oral Surgery Department, College
of Dentistry-University of Mosul. The samples of saliva were collected and salivary flow rates and
total protein was determined for each individual, then its relation to oral health was measured accord-
ing to Simplified Oral Hygiene Index by Greene and Vermillion. Results: One way analysis of variance
was performed and showed that their were significant differences among all study groups for both sali-
vary flow rate and total salivary protein concentration .The results of Duncan's Multiple analysis range
test showed that there were no significant differences in salivary flow rates and total salivary protein
concentrations between first and third groups while significant differences were seen between first and
second and between second and third groups .For oral health scores , there was no significant differ-
ences between first and third groups while significant differences were observed between first and se-
cond and between second and third groups. Conclusions: Changes in salivary flow rates and salivary
protein concentrations can result from diabetes mellitus which can affect oral health of these patients,
while oral hypoglycemic drugs had no such effects.
Key Words: Diabetes Mellitus, salivary flow rate, salivary proteins, oral hypoglycemic drugs.
Al - Mashhadane FAM. Effects of Oral Hypoglycemic Drugs on Flow Rate and Protein Composition
of Saliva in Patients with Diabetes Mellitus. Al–Rafidain Dent J. 2011; 11(2): 297-302.
Received: 11/3/2010 Sent to Referees: 15/3/2010 Accepted for Publication: 18/4/2010
action, or both (2). It can be treated by oral formed at the same time of day (2 hr after
hypoglycemic drugs such as sulfonylureas having breakfast) to avoid circadian varia-
and metformin (3). Both diabetes mellitus tions (12, 13), each subject was asked to wash
and drugs used in the treatment of this dis- his\her mouth three times with distilled
ease can affect the mouth and salivary water and to take drops of a sugar free
glands (4). lemon juice before spitting. Saliva volume
The oral complications of uncon- was measured, placed in a test tube then
trolled diabetes mellitus are devastating. closed with a plastic stopper and stored in
These may include xerostomia, salivary deep freeze until the time of experiment
gland dysfunction, gingivitis and perio- (14)
. Total protein for each sample of saliva
dontal disease and this is related to several was determined using Biuret method by
pathological events associated with diabe- mixing of 0.2 ml of saliva with 2.8 ml of
tes (5).Several classes of drugs were associ- distilled water and then adding 5 ml of
ated with dry mouth and salivary gland Biuret reagent which was prepared by
dysfunction or hypofunction which may
dissolving 9 gm of sodium potassium tar-
influence concentrations of salivary pro-
rate in 500 ml of 0.2 N-sodium hydroxide
teins leading to changes of oral health sta-
tus among individuals using these drugs (6, , adding 3 gm of copper sulfate and dis-
7, 8)
.Since saliva is a diagnostic medium solved by stirring , then 5gm of potassium
that can be easily collected with minimal iodide was added to make the volume 4 L
invasion (9),this study was conducted to with 0.2 N – sodium hydroxide (12-15)
investigate the effects of both Diabetes .Ultraviolet visible spectrophotometer
Mellitus and antidiabetic drugs on salivary (CECIL, CEIO021, England) at wave
flow rate and total protein concentrations length of 540 nm was used to determine
of saliva compared to control healthy sub- the total protein in saliva sample. For in-
jects and to determine their effects on oral vestigation of salivary flow rates, all sub-
health of these patients. jects were told not to eat, drink or smoke
MATERIALS AND METHODS for 1 hr before each sampling. The saliva
Forty – five individuals have partici- samples were always collected in restful
pated in this study, their age ranged be- and quiet circumstances, unstimulated
tween 35 - 65 years with mean age of whole saliva was collected for 5 min by
50±1 years. Fifteen of them were healthy the subjects leaning forward and letting the
individuals and considered as control saliva drain into a graded sampling tube,
group, while the other 15 individuals were the flow rates were evaluated visually
suffering from diabetes mellitus and re- from graded test tubes as ml \min (16).
ceived no any treatment (uncontrolled). On other hand, oral hygiene for each
individual was evaluated by Simplified
The third group was diabetic patients
Oral Hygiene Index according to Greene
treated with metformin only with dose
and Vermillion .It consist of two compo-
ranged 500 - 1000 mg\ day. The duration nents, a Simplified - Debris Index and a
of disease for both second and third groups Simplified - Calculus Index, each compo-
ranged between 3-11 years (mean 7 ± 1 nent was assessed on a scale of 0 - 3. On-
year). All these individuals were selected ly mouth mirror and sickle type dental ex-
from out - patient clinic at Oral Surgery plorer were used for the examinations. The
Department, College of Dentistry, Univer- criteria for scoring the debris and calculus
sity of Mosul. A questionnaire was con- components of the Simplified Oral Hy-
ducted to subjects and those who reported giene Index are as follows: Oral – Debris
to have diabetes were requested to present Index [DI-S]:
their medical records and\or prescriptions 0 = no debris or stain present.
which confirmed their diabetes status. 1 = soft debris covering not more than one
Subjects were seated on a chair under quit third of the surface or the presence of ex-
standardized condition (10, 11). The samples trinsic stains without other debris regard-
of stimulated saliva were collected from less of surface area covered.
45 individuals using spitting method .The 2 = soft debris covering more than one
time of collection was 5 continuous third but not more than two thirds of the
minutes (without swallowing), it was per- exposed tooth surface.
SD = standard deviation; *Significant difference at p≤ 0.05; ** Different letters mean a significant dif-
ference exists.
Table (2): Analysis of variance of salivary flow rates in all study groups
1st group 2nd group 3rd group
P-value F –value
(normal) (uncontrolled) (controlled)
Salivary flow rate
(ml/min) (mean ± 4.00±1.31 1.80±0.77 3.87±0.83 0.000* 22.750
SD)
Duncan's group-
B A B
ing
SD = standard deviation; *Significant difference at p≤ 0.05; ** Different letters mean a significant dif-
ference exists.
For oral health scores, also it was significant differences were observed be-
found that there is no significant differ- tween second and third groups (p< 0.007 ),
ences between first and third groups, while as shown in Table 3.
Table (3): Analysis of variance of oral health scores in all study groups
1st group 2nd group 3rd group P-value F -value
(normal) (uncontrolled) (controlled)
Oral health scores
5.8±10.7 4.21±0.935 3.87±0.834
(mean±SD) 0.007* 5.724
Duncan’s grouping A B A
SD = standard deviation; * Significant difference at p≤ 0.05; ** Different letters mean a significant
difference exists.
tionship to non oral symptoms, drugs 19. Loe H. Periodontal disease: the sixth
and diseases. Oral Surg Oral Med complication of diabetes mellitus. Di-
Oral Pathol. 1989, 68 (4): Pp 419 – abetes care. 1993; 16: Pp329-334.
27. 20. Dodds M, Johnson D, and Yeh C.
7. Scully C, Drug effects on salivary Health benefits of saliva: a review. J
glands: dry mouth. Oral diseases. Dent, 2005, 33 (3): Pp 223-33.
2003, 9: Pp 165 – 176. 21. Leite M and Nicolau J. Sodium tung-
8. Johnson D and Cortez J. Chronic state on some biochemical parameters
treatment with beta adrenergic agonists of the parotid salivary gland of strep-
and antagonists alter the composition tozotocin – induced diabetic rats: a
of proteins in rat parotid saliva. J Dent short- term study. Biol Trace Elem
Res. 1988; 167: Pp1103 – 1108. Res. 2009, 127(2): Pp154-63.
9. Pink R, Simek J, and Vondrakova J. 22. Ben-Aryeh H, Cohen M, and Kanter
Saliva as a diagnostic medium. Biomed Y. Salivary composition in diabetic pa-
Pap Med Fac Univ Palacky Olomouc tients. J Diabet Complications. 1988;
Czech Repub. 2009; 153 (2): Pp 103- 2(2): Pp 96-9.
10. 23. Dodds M, Yeh C, and Johnson D. Sal-
10. Al-Nuaimy K. Pregnancy related ivary alterations in type 2 (non insulin-
changes in human unstimulated whole dependent) diabetes mellitus and hy-
saliva and oral health. Msc. Thesis pertension. Community Dent Oral Epi-
.College of Medicine. University of demiol. 2000, 28(5): Pp 373- 81.
Mosul. 2002. 24. Rudney J. Dose variability in salivary
11. Tahani A, Fayhaa A, and Amer T. Sal- protein concentrations influences oral
ivary protein components and oral microbial ecology sand oral health?
health in patients undergoing therapy Crit Rev Oral Biol Med. 1995; 6(4):
with Beta – adrenergic agonist and an- Pp343-67.
tagonist. Al-Rafidain Dent J. 2008; 25. Proctor G, Pramanik R, and Carpenter
8(2): Pp219 – 224. G. Salivary proteins interact with die-
12. Woodbury G .Determination of pro- tary constituents to modulate tooth
tein, in: Physical chemistry. 1st ed. staining. J Dent Res; 2005, 84(1): Pp
Brook I\cole Publishing Company. 73 - 78.
1997: Pp 325-326. 26. Zhang J, Pan Y, and Ma L. A survey
13. Burtis C, Ashwood E. Proteins, in: on the periodontal status in type 2 dia-
Fundamentals of clinical chemistry, betic patients. Zhonghuakou Qiang yi
Vol.1. 5thed. W.B. Saunders Company. xue za zhi, 2009; 44 (11): Pp668 – 71.
2001: P 325. 27. Vesterinen M, Ruokonen H,and Fu-
14. Elfenbaum K. The role of biochemical ruholm J. Oral health in predialysis pa-
study of the saliva in diagnosis of dis- tients with emphasis on diabetic
eases. J Am Dent Assoc. 1988; 129(6): nephropathy. Clin Oral Investig. 2010:
Pp733-739. 19.
15. Maria E, Rafael G, Judit N. Salivary 28. Sreebny L, Yu A, Green A, and Val-
characteristics of diabetic children. dini A. Xerostomia in diabetes melli-
Braz Dent J, 2003; Vol. 14 (1) . tus. Diabetes care. 1992; 15(7):
16. Ben- Aryeh H , Serouya R , Kanter Y, Pp900-4.
Szargel R, and Laufer D. Oral health 29. Busato I, Ignacio S, and Brancher J.
and salivary composition in diabetic Impact of xerostomia on the quality of
patients. J Diabetes Complications. life of adolescents with type 1 diabetes
1993, 7: Pp 5762. mellitus .Oral Surg Oral Med Oral
17. Fermin A, and Michael G .Simplified pathol Oral Radiol Endod. 2009; 108
Oral Htgeine Index, in: Clinical perio- (3): Pp376 - 82.
dontology. 8th ed. WB Saunders Com- 30. Von Bultzing slowen I, Sollecito T,
pany. 1996: Pp 67-68. and Fox P .Salivary dysfunction asso-
18. Moreira A, Passos I, and Sampaio F. ciated with systemic diseases: System-
Flow rate, PH and calcium concentra- atic review and clinical management
tion of saliva of children and adoles- recommendations. Oral Surg Oral
cents with type 1 diabetes mellitus. Med Oral Pathol Oral Radiol Endod.
Braz J Med Biol Res. 2009; 42 (8): Pp 2007; 103: s57-15.
707 - 11. 31. Reiss M and Reiss G. Dry mouth. Med